Page last updated: 2024-09-03

imatinib mesylate and Intestinal Neoplasms

imatinib mesylate has been researched along with Intestinal Neoplasms in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (28.57)	29.6817
2010's	25 (59.52)	24.3611
2020's	5 (11.90)	2.80

Authors

Authors	Studies
Chen, X; Gong, Z; Ju, RH; Qu, H; Ren, Y; Shao, S; Xu, Z; Zhang, F	1
Aoyama, T; Atsumi, Y; Higuchi, A; Kano, K; Kato, A; Kawabe, T; Kazama, K; Murata, M; Nakazono, M; Numata, M; Rino, Y; Saeki, H; Sawazaki, S; Takahashi, A; Tamagawa, H; Tanaka, S; Yukawa, N	1
Aghmesheh, M; Daly, D; Gandy, R; Goldstein, D; Symons, R	1
Chapman, TP; Kennedy, J; Satsangi, J	1
Aoki, T; Imoto, H; Kamei, T; Karasawa, H; Kohyama, A; Motoi, F; Musha, H; Naitoh, T; Ohnuma, S; Ono, T; Suzuki, H; Tanaka, N; Unno, M; Watanabe, K; Yamamura, A	1
Akami, T; Hatakeyama, T; Komiyama, S; Mazaki, T; Ogino, S; Sakai, K; Tamai, H; Ueda, Y	1
Abood, G; Baker, MS; Eguia, E; Knab, L; Lutfi, W; Patel, DJ; Sweigert, P	1
Fujikawa, Y; Hasuo, K; Jin, Y; Kakazu, A; Koumori, K; Masuda, M; Mikayama, Y; Watanabe, T	1
Akabori, H; Iida, H; Kaida, S; Kitamura, N; Miyake, T; Mori, T; Shimizu, T; Sonoda, H; Takebayashi, K; Tani, M; Terada, Y; Ueki, T; Yamaguchi, T	1
Fukumoto, K; Hirajima, S; Kobayashi, H; Takagi, T	1
Antonescu, CR; Jain, S; Martz, J; Mosquera, JM; Popa, EC; Qin, L; Vahdat, LT	1
Akahoshi, S; Inoue, K; Kiyota, Y; Kiyozumi, Y; Motooka, Y; Yamaguchi, R; Yoshida, Y	1
Ikehara, T; Inoue, T; Kanazawa, A; Nishiguchi, Y; Shimizu, S; Toyokawa, T; Tsukamoto, T; Yamamoto, A; Yamashita, Y	1
Chen, L; Liu, L; Liu, Y; Wu, X; Xu, W	1
Hosaka, S; Kawamoto, S; Kikutake, T; Nagao, S; Umemoto, S; Yonemitsu, K; Yoshida, T	1
Chong, H; Hagi, T; Ichikawa, Y; Ishikawa, S; Kanazawa, A; Lee, K; Maeda, T; Maruyama, K; Nishihara, M; Oka, H; Shimada, M; Takayama, S; Taniura, N; Ueno, G	1
Kang, YK; Kim, BS; Koh, YW; Park, HJ; Park, YS; Ryoo, BY; Ryu, MH; Yoo, C; Yook, JH	1
Björk, J; Classon, J; Clevers, H; Frisén, J; Genander, M; Kundu, P; Martling, A; Pettersson, S; Ridgway, RA; Sansom, OJ; Strååt, K; Tan, EH; van Es, J	1
Kim, CW; Kim, HY; Seo, KJ; Whang, IY; Won, HS	1
Azouz, MM; Bouassida, M; Chelbi, E; El Bouchtili, S; Ezzine, H; Hamzaoui, L; Mahmoudi, M; Medhioub, M; Touinsi, H	1
Kayaselçuk, F; Koç, Z; Ulusan, S	1
Akyurek, N; Benekli, M; Buyukberber, S; Coskun, U; Demirci, U; Karakan, T; Tonyali, O; Yildiz, R	1
Briaire-de Bruijn, IH; Gelderblom, H; Hogendoorn, PC; Jordanova, ES; Ottenhoff, TH; Savage, ND; van der Burg, SH; van Dongen, M; van Hall, T; Walburg, KV	1
Benekli, M; Bilge Yilmaz, I; Buyukberber, S; Coskun, U; Demirci, U; Erdem, O; Ozturk, B	1
Bellosillo, B; Iglesias, M; Martínez-Avilés, L; Pera, M; Puig, S	1
Bonkobara, M; Ishii, N; Ito, K; Kobayashi, M; Kuroki, S; Ono, K; Sasaki, Y; Sugisaki, O; Washizu, T; Yamada, O	1
Ashley, SW; Grover, S; Raut, CP	1
Hazama, S; Inoue, Y; Oka, M; Suzuki, N; Yoshino, S	1
Inoue, M; Itoh, G; Matsuzaki, T; Ogawa, M; Osaka, H; Yamamoto, T	1
Andersen, MK; Gerdes, AM; Hansen, TV; Wadt, K	1
Gudlaugsson, E; Haugland, HK; Mangseth, K; Sandvik, OM; Søreide, JA; Søreide, K	1
Brugarolas, A; Calvo, E; Fernández, FJ; Forteza, J	1
Scoazec, JY	1
Gräter, H	1
Hasuike, Y; Kawahara, K; Kurata, A; Mishima, H; Mukaide, H; Nishisyou, I; Shin, E; Takeda, Y; Tujinaka, T	1
Dudek, K; Grzesiakowska, U; Krawczyk, M; Nasierowska-Guttmejer, A; Nowecki, ZI; Nyckowski, P; Pienkowski, A; Ruka, W; Rutkowski, P	1
Eide, J; Haugland, HK; Horn, A; Jebsen, NL; Jensen, DK; Lilleng, PK; Mannelqvist, M; Monge, OR; Skar, R; Øvrebø, K	1
Efron, DT; Lillemoe, KD	1
Chang, HM; Kang, HJ; Kang, YK; Kim, TW; Lee, JL; Lee, JS; Ryu, MH; Sohn, HJ	1
Hanada, N; Inoue, K; Kawamura, Y; Osako, T; Taneda, T; Yoshida, Y	1
Chen, TW; Hsueh, S; Jan, YY; Wu, TJ; Yeh, CN	1
Araujo, DM; Esmaeli, B; Espandar, L; Hatef, E; Kim, SK; Shome, D; Song, CD; Trent, J	1

Reviews

5 review(s) available for imatinib mesylate and Intestinal Neoplasms

Article	Year
Progress in the Treatment of Small Intestine Cancer. Current treatment options in oncology, 2023, Volume: 24, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Neuroendocrine Tumors	2023
Small intestine gastrointestinal stromal tumors. Current opinion in gastroenterology, 2012, Volume: 28, Issue:2 Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Neoadjuvant Therapy; Neoplasm Metastasis; Piperazines; Prognosis; Pyrimidines; Pyrroles; Sunitinib	2012
[c-kit: an irresistible ascension from diagnostic marker to therapeutic]. Annales de pathologie, 2002, Volume: 22, Issue:3 Topics: Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Enzyme Inhibitors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Mutation; Neoplasms; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Stomach Neoplasms	2002
[Tumors of the small intestine]. Praxis, 2002, Oct-09, Volume: 91, Issue:41 Topics: Adenocarcinoma; Adenoma; Adenomatous Polyposis Coli; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Diagnosis, Differential; Duodenal Neoplasms; Genetic Predisposition to Disease; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Risk	2002
The current management of gastrointestinal stromal tumors. Advances in surgery, 2005, Volume: 39 Topics: Benzamides; Chemotherapy, Adjuvant; Colonic Neoplasms; Decision Trees; Esophageal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Intestinal Neoplasms; Magnetic Resonance Imaging; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Rectal Neoplasms; Risk Assessment; Stomach Neoplasms; Tomography, X-Ray Computed	2005

Trials

2 trial(s) available for imatinib mesylate and Intestinal Neoplasms

Article	Year
Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate. World journal of gastroenterology, 2006, Jun-21, Volume: 12, Issue:23 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Exons; Female; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Mutation; Piperazines; Platelet-Derived Growth Factor; Prognosis; Prospective Studies; Proto-Oncogene Proteins c-kit; Pyrimidines; Survival Rate; Treatment Outcome	2006
Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine. Ophthalmology, 2008, Volume: 115, Issue:3 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Corneal Ulcer; Drug Resistance, Neoplasm; Female; Gastrointestinal Stromal Tumors; Glucocorticoids; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Phosphorylcholine; Piperazines; Prednisolone; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies	2008

Article

Year

Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate.

World journal of gastroenterology, 2006, Jun-21, Volume: 12, Issue:23

Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Exons; Female; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Mutation; Piperazines; Platelet-Derived Growth Factor; Prognosis; Prospective Studies; Proto-Oncogene Proteins c-kit; Pyrimidines; Survival Rate; Treatment Outcome

2006

Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine.

Ophthalmology, 2008, Volume: 115, Issue:3

Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Corneal Ulcer; Drug Resistance, Neoplasm; Female; Gastrointestinal Stromal Tumors; Glucocorticoids; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Phosphorylcholine; Piperazines; Prednisolone; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies

2008

Other Studies

35 other study(ies) available for imatinib mesylate and Intestinal Neoplasms

Article	Year
The analysis of prognostic factors of primary small intestinal gastrointestinal stromal tumors with R0 resection: A single-center retrospective study. Medicine, 2022, Jun-24, Volume: 101, Issue:25 Topics: Adult; Aged; Aged, 80 and over; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Ki-67 Antigen; Male; Middle Aged; Prognosis; Retrospective Studies; Young Adult	2022
[A Case of Curative Surgery for Locally Advanced Small Bowel GIST after Imatinib Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:10 Topics: Antineoplastic Agents; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Neoadjuvant Therapy	2022
Just Another Flare of Ulcerative Colitis? Gastroenterology, 2020, Volume: 158, Issue:8 Topics: Aged; Antineoplastic Agents; Biopsy; Colitis; Colitis, Ulcerative; Colonoscopy; Diagnosis, Differential; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Symptom Flare Up	2020
[A Case of Peritoneal Metastasis Resection from GIST of the Small Intestine with Focal Resistance Against Imatinib Mesylate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:13 Topics: Aged; Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Male; Peritoneal Neoplasms; Proto-Oncogene Proteins c-kit	2019
[A Case of Omental Desmoid Tumor after a Small Bowel Resection for Gastrointestinal Stromal Tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:13 Topics: Aged; Fibromatosis, Aggressive; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Omentum	2019
Adjuvant systemic therapy for small bowel gastrointestinal stromal tumor (GIST): Is there a survival benefit after R0 resection? Surgery, 2020, Volume: 168, Issue:4 Topics: Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Proportional Hazards Models; Retrospective Studies	2020
[A Case Survived Long Period after Repeated Operation against the Small Intestinal GIST with Perforation]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:1 Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestinal Perforation; Male; Middle Aged; Prognosis; Recurrence; Time Factors	2018
[A Case of Small Intestinal GIST with Long-Term Survival after Tumor Resection for Repeated Peritoneal Recurrence]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12 Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Peritoneal Neoplasms; Recurrence; Time Factors	2017
[A Case of Gastrointestinal Stromal Tumor of the Small Intestine Complicated by Hemorrhagic Shock Due to Gastrointestinal and Intraperitoneal Bleedings]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12 Topics: Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Intraoperative Complications; Male; Shock, Hemorrhagic	2017
High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11 Topics: Aged; Benzamides; Dasatinib; Diagnosis, Differential; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Thiazoles; Vimentin	2013
[A case of imatinib-resistant gastrointestinal stromal tumor treated with low-dose sunitinib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:13 Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Recurrence; Salvage Therapy; Sunitinib	2013
[Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Recurrence; Stomach Neoplasms; Treatment Outcome	2014
[Efficacy and prognosis of different treatments on 63 patients with small intestinal gastrointestinal stromal tumors]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2014, Volume: 17, Issue:4 Topics: Antineoplastic Agents; Benzamides; Disease-Free Survival; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Neoplasm Recurrence, Local; Piperazines; Prognosis; Pyrimidines; Retrospective Studies	2014
[A case of small intestinal gastrointestinal stromal tumor (GIST) with peritoneal dissemination, treated effectively with molecular target drug after operation]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Molecular Targeted Therapy; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Sunitinib	2014
[A case of extragastrointestinal stromal tumor with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2014
Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib. Annals of surgical oncology, 2015, Volume: 22 Suppl 3 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cohort Studies; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Tumor Suppressor Protein p53; Young Adult	2015
An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth. Science translational medicine, 2015, Apr-01, Volume: 7, Issue:281 Topics: Adenoma; Animals; Carcinogenesis; Cell Proliferation; Ephrin-B2; Genes, APC; Imatinib Mesylate; Intestinal Neoplasms; Longevity; Mice; Proto-Oncogene Proteins c-abl; Signal Transduction; Tumor Suppressor Proteins	2015
A huge necrotic liver mass in a 45-year-old woman: delayed hepatic metastasis of a gastrointestinal stromal tumor. The Korean journal of internal medicine, 2017, Volume: 32, Issue:2 Topics: Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Intestinal Neoplasms; Liver Neoplasms; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Time Factors; Treatment Outcome; Tumor Burden	2017
Gastrointestinal stromal tumours (GISTs): A descriptive study on 29 cases. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2016, Volume: 17, Issue:4 Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Proto-Oncogene Proteins c-kit; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib; Survival Rate; Tumor Burden; Weight Loss	2016
Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2008, Volume: 19, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Colon; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Liver; Liver Neoplasms; Male; Neoplasm Invasiveness; Piperazines; Pyrimidines; Stomach; Stomach Neoplasms; Ultrasonography	2008
Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Acute Disease; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Liver; Liver Failure; Middle Aged; Peritoneal Neoplasms; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sunitinib	2010
Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors. International journal of cancer, 2010, Aug-15, Volume: 127, Issue:4 Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Benzamides; Female; Forkhead Transcription Factors; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Indoles; Interleukin-10; Intestinal Neoplasms; Macrophages; Male; Piperazines; Prognosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptors, Cell Surface; Sunitinib; T-Lymphocytes, Regulatory	2010
Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:3 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Biopsy; Gastrointestinal Stromal Tumors; Histamine Antagonists; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Keratoderma, Palmoplantar; Liver Neoplasms; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rosacea; Skin; Skin Pigmentation; Sunitinib; Treatment Outcome	2011
A sporadic multiple gastrointestinal stromal tumor with unique clinical and molecular features. Human pathology, 2011, Volume: 42, Issue:8 Topics: Antineoplastic Agents; Benzamides; Combined Modality Therapy; Exons; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Mutation; Neoplasms, Multiple Primary; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Treatment Outcome	2011
Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy. Veterinary journal (London, England : 1997), 2012, Volume: 193, Issue:1 Topics: Animals; Antineoplastic Agents; Benzamides; Dog Diseases; Dogs; Female; Imatinib Mesylate; Intestinal Neoplasms; Mastocytosis, Systemic; Phosphorylation; Piperazines; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-kit; Pyrimidines; Treatment Outcome	2012
[A case of gastrointestinal stromal tumor (GIST) successfully treated with resection after a long-term control medication by molecular targeted drugs]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12 Topics: Antineoplastic Agents; Benzamides; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Piperazines; Pyrimidines; Pyrroles; Sunitinib; Tomography, X-Ray Computed	2011
[A case of long survival after resection and treatment with imatinib mesylate against metachronous liver metastases and a lung metastasis of a small intestine gastrointestinal stromal tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Liver Neoplasms; Lung Neoplasms; Male; Piperazines; Pyrimidines; Time Factors; Tomography, X-Ray Computed	2012
[A new genetic diagnosis of familiar gastrointestinal stromal tumour]. Ugeskrift for laeger, 2012, May-21, Volume: 174, Issue:21 Topics: Aged; Antineoplastic Agents; Benzamides; Family; Fatal Outcome; Female; Gastrointestinal Stromal Tumors; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Mutation, Missense; Pigmentation Disorders; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines	2012
Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2012, Volume: 14, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Disease-Free Survival; DNA Mutational Analysis; Exons; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Risk Assessment; Stomach Neoplasms	2012
[Effect of STI-571, a c-kit tyrosine kinase inhibitor, in mestastasic gastrointestinal tumor]. Medicina clinica, 2002, Sep-28, Volume: 119, Issue:10 Topics: Adult; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma	2002
[A patient with diffuse peritoneal metastases of GIST who was administered STI571]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:12 Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Intestinal Neoplasms; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines	2002
The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST). Neoplasma, 2003, Volume: 50, Issue:6 Topics: Adult; Aged; Benzamides; Combined Modality Therapy; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Hepatectomy; Humans; Imatinib Mesylate; Intestinal Neoplasms; Liver Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Reoperation; Retrospective Studies; Stomach Neoplasms; Time Factors; Tomography, X-Ray Computed	2003
[Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2005, Apr-07, Volume: 125, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Esophageal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Piperazines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Stomach Neoplasms; Treatment Outcome	2005
Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate. Japanese journal of clinical oncology, 2006, Volume: 36, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Decision Making; Disease Progression; Drug Administration Schedule; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Piperazines; Prognosis; Prospective Studies; Pyrimidines; Remission Induction; Stomach Neoplasms; Survival Analysis; Tomography, Spiral Computed	2006
[A case of recurrent GIST successfully treated with low-dose imatinib mesilate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:6 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Administration Schedule; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Male; Neoplasm Recurrence, Local; Pelvis; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Pyrimidines	2006